Therapeutic Potential of Psychedelics in Treatment of Psychiatric Disorders, Part 2
The Journal of Clinical Psychiatry February 23, 2021 Avinash Hosanagar, Joseph Cusimano, Rajiv Radhakrishnan 1 citation
P sychedelics have recently gained attention as compounds with therapeutic potential in the treatment of psychiatric disorders.The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designations for (±)-3,4-methylenedioxymethamphetamine (MDMA) as an adjunct to psychotherapy in severe posttraumatic stress disorder (PTSD) (in 2017) and for the adjunctive use of psilocybin with...